individuals, T allele carriers showed higher DBP than GG genotype. Conclusion The present study evidenced that rs1799983 NOS3 polymorphism could be associated with hypertension and DBP among Southern Europeans, being this association influenced by dietary fat (SFA and MUFA) and body mass index.
Introduction
Hypertension contributes to the burden of heart disease, stroke, kidney failure and premature mortality [1] . In fact, hypertension complications account for 9.4 million deaths worldwide every year [2] . Key risk factors include age, race, endocrine and metabolic disorders, lifestyle behaviors and genetics, among others [1] .
In this context, familial and twin studies have estimated the heritable component of blood pressure (BP) to be about 30-60 % [3] . Moreover, genomewide association studies (GWAS) have identified a large number of polymorphisms associated with BP or hypertension, which are located in or near genes involved in the renin-angiotensin-aldosterone system, related to enzymes and receptors of the mineral and glucocorticoid pathways and associated with proteins implicated in the structure and/or regulation of vascular tone [4] .
Among them, the nitric oxide synthase (NOS3) gene is regarded as one of the putative candidate genes for BP regulation and hypertension, since it is involved in the production of nitric oxide (NO) which has vasodilator effects (i.e.,
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Therefore, the aims of the present research were to examine the potential association between the rs1799983 NOS3 genetic variant and BP levels and hypertension, and to investigate the possible influence of non-genetic risk factors on that association.
Methods

Study population
The present study encompassed men and women of Caucasian ancestry who voluntarily attended community pharmacies located in seven regions of Spain (Barcelona, Zaragoza, La Coruña, Pontevedra, Madrid, Granada and Málaga). Genotype information of 718 individuals was available. Of these, 13 subjects were excluded with missing values for dietary intake, physical activity, anthropometric measurements and/or blood pressure levels. Therefore, the screened group included 705 individuals with a mean age of 50.2 ± 13.2 y.o. Of the total population, 22.3 % (n 157) were male and 77.7 % (n 548) were female.
The recruited subjects were specifically asked whether they would be willing to take part anonymously in the research study. Only those who gave written informed consent for participation were enrolled. All procedures were in accordance with the guidelines laid down in the Declaration of Helsinki. Patient data were codified to guarantee anonymity. The Research Ethics Committee of the University of Navarra provided confirmation of fulfillment of the ethical standards affecting this research (Ref. 2410 (Ref. /2014 .
Anthropometric measurements, habitual dietary intake and physical activity were collected by trained nutritionists as described elsewhere [11] . Briefly, weight, height, waist circumference and body fat mass were measured with a digital scale (Tanita BF-522W, Tanita Corporation, Tokyo, Japan), a portable stadiometer (Leicester Tanita), inextensible tape measure and bioelectrical impedance (Tanita BF-522W), respectively. Dietary intake was determined using a food frequency questionnaire in which basic foods were classified into 19 food groups, where four responses were possible (daily, weekly, monthly or never). Physical activity was collected by a short 24-h physical activity questionnaire [12] .
Blood pressure
BP was measured using the following standardized protocol with a validated automatic device (MIT Elite Plus, OMRON Healthcare, Hoofddorp, the Netherlands) and appropriately sized cuff [13] . Measurements were carried out in the non-dominant arm, with the elbow at the level of the right atrium and with the subject in a sitting position. Systolic BP (SBP) and diastolic BP (DBP) were taken two times, separate of at least 10 min. The last measurement was used in the analysis, discarding the first one. If in the second reading the SBP or DBP were ≥140 or ≥90 mmHg, respectively, was performed a third measurement.
BP was considered as a categorized variable (hypertension vs. normotension) and as a continuous variable. In order to dichotomize variables, individuals with a SBP ≥ 140 mmHg or DBP ≥ 90 mmHg or with declared diagnostic hypertension were defined as "hypertensive." On the other hand, as a continuous variable, BP was treated after adjustment of the BP treatment. In this sense, according to previous studies and based on the known average treatment effects, fixed increment of 15 mmHg SBP and 10 DBP was added to the pressures of individuals with diagnostic hypertension [14] [15] [16] [17] .
DNA isolation and genotyping
Genomic DNA was isolated from oral epithelial cells (collected by ORAcollect DNA ® , DNAGenotek, Kanata, Canada) by QIAcube using QiAmp DNA Mini QIAcube Kit (Qiagen, Hilden, Germany), following the manufacturer's standard protocol. rs1799983 NOS3 genetic variant was genotyped by Luminex ® 100/200TM System (Luminex Corporation, Austin, Texas), which is based on the principles of xMAP ® Technology. This method uncompressed polystyrene microspheres internally dyed with various ratios of spectrally distinct fluorochromes that are detected by a flow cytometry-based instrument [18] .
Statistical analysis
Examination of Hardy-Weinberg equilibrium (HWE) was assessed using the chi-square test, and allele frequencies were estimated. Quantitative variables are expressed as means (SD), and differences among genotype groups were analyzed using general linear models of analysis of covariance (ANCOVA) with age, gender, energy intake and physical activity as covariates. Multiple logistic regression (categorical variable) and multiple linear regression models (continuous variables), adjusted for covariates (model A adjusted for non-modifiable factors and model B adjusted for model A plus modifiable factors), were applied to investigate the association of the NOS3 polymorphism with hypertension and SBP/DBP, respectively. Interactions between rs1799983 (as a dummy variable) and weight status or dietary fatty acid intake on BP were investigated using likelihood ratio test, once adjusted for potential confounders including gender, age, physical activity, energy intake, smoking status and alcohol consumption. All statistical procedures were performed using STATA/SE version 12.0 (StataCorp, College Station, TX, USA). Tests were considered statistically significant at p value <0.05.
Results
Minor allele frequency (MAF) (T = 36.9) and genotypic frequencies (GG = 40.1, GT = 46.0, TT = 13.9) for rs1799983 were in accordance with the reference data for Caucasian populations (HapMap CEU). Moreover, the distribution of the polymorphism was in Hardy-Weinberg equilibrium (HWE) (p > 0.05). Baseline characteristics of the population have been described according to rs1799983 NOS3 genotype subgroups (Table 1 ). There were no statistically significant differences based on genotype for anthropometrical, physical activity and dietary variables. Of the 705 individuals, 22.3 % (n 157) selfdeclared hypertension. Moreover, about 30.6 % of the individuals self-declared that they suffered one or more metabolic disorders: 3.3 % type two diabetes, 28.6 % different lipid metabolism impairments and 3.1 % cardiovascular disease.
Logistic regression models to estimate odds ratios of self-declared hypertension for individuals with the rs1799983 polymorphism were analyzed (Fig. 1) . Once adjusted for covariates, those subjects with the TT genotype showed a statistically significant 2.30-fold higher predisposition of hypertension (95 % CI 1.18-4.44; p 0.014) than those subjects with the GG genotype. However, individuals with the GT genotype did not show a higher risk Results from linear regression analyses showed an association between rs1799983 and DBP. Nevertheless, no relationship with SBP was found ( Table 2 ). Carriers of the T allele had significantly greater values of DBP and DBP corrected according to treated hypertensive subjects after adjusted for non-modifiable risk factors of hypertension and both non-modifiable and modifiable risk factors of hypertension. Specifically, each additional risk allele was associated with a 1.99 mmHg increase in DBP, when DBP was adjusted according to treated hypertensive subjects and after statistical analysis was adjusted for gender, age, smoking status, alcohol consumption and physical activity. Moreover, GT and TT individuals showed a 2.55 mmHg higher DBP than GG individuals after adjusted for non-modifiable and modifiable covariates. Upon stratifying data by gender, similar results were found among men (data not shown).
After data were adjusted for potential confounder variables, saturated fatty acids (SFA) and monounsaturated fatty acids (MUFA) modified the effect of the rs1799983 NOS3 genetic variant on DBP (Fig. 2) . The influence of Body Mass Index (BMI) on the association between rs1799983 and DBP was also analyzed (Fig. 3) . When the analysis was carried out according to the three genotype groups, no significant interactions were found. In contrast, when GT and TT genotypes were clustered, a significant interaction was found. Among normal weight individuals, no significant differences were found in DBP between GG genotype subjects and GT and TT genotype subjects. However, among overweight individuals GT and TT genotype subjects showed higher DBP than TT genotype subjects. 
Discussion
The current study provides evidence that rs1799983 NOS3 genetic variant is associated with an increased odds of hypertension and a high to normal DBP in Southern Europeans. Interestingly, an interaction between BMI and dietary fat intake (SFA and MUFA), with the rs1799983 polymorphism to influence DBP levels was observed.
In the last few years, increased attention was paid to this NOS3 polymorphism since it is directly involved in BP regulation through NO levels [5] . A meta-analysis involving 45,287 subjects identified that the T allele of the rs1799983 polymorphism was associated with hypertension predisposition with an odds ratio of 1.20 (p 0.015) [8] . However, when the population was stratified for ethnicity, no significance was reached for Whites (OR 0.99, p 0.828). It should be highlighted that most of the studies in European population, included in the meta-analysis, were carried out in North and Central Europe. In line of our results, a study in American white women revealed a hazard ratio of hypertension for rs1799983 NOS3 genetic variant of 1.05 (p 0.03) [19] . Afterward, reports linked the rs1799983 not only to hypertension, but also to left ventricular hypertrophy, coronary artery disease and venous thromboembolism, among others [20] [21] [22] . In the rs1799983 polymorphism, a guanine/thymine substitution at exon seven leads to a glutamate/aspartate substitution at position 298. Since this genetic variant alters the primary structure of the protein and could alter one or more functional properties of the enzyme, several mechanistic studies have been carried out [23] [24] [25] [26] [27] . Different reports have revealed that in the presence of a T instead of a G at nucleotide position 894, NOS3 encodes a protein which leads to a higher susceptibility to cleavage into a 100-kDa fragment [23, 24] . Thus, the cleaved fragment could decrease NOS3 activity. However, other studies concluded that this finding might be a technical artifact [25, 26] . On the other hand, it has been confirmed that T allele carriers have less NOS3 bound to caveolin-1, which is a protein essential for its activation and therefore to endothelial cell NO production [27] .
To our knowledge, two previous studies have suggested an influence of rs1799983 NOS3 genetic variant on DBP [28, 29] . The research by Kimura et al. [28] , in Africanderived Brazilian population, revealed a single two-locus effect between rs1799983 and rs1801058, NOS3 and GKR4 variants, respectively, on DBP. Lately, Nunes et al. [29] showed that GG genotype subjects presented lower exercise DBP than T allele carriers, among Brazilian women. Nevertheless, Seidlerová et al. [30] failed to confirm in Europeans the relationship between rs1799983 and any arterial properties. It should be mentioned that DelgadoLista et al. [31] reported that after a meal rich in SFA the microvascular endothelial function, which is a subclinical condition found in most patients with hypertension, was lower among TG and GG genotype subjects than TT genotype subjects of a Spanish population. In one hand, this finding suggests a possible ethnic influence on genetic modulation of BP levels responses. On the other hand, as other authors have previously suggested gene-environmental interactions should be analyzed [8] .
In addition to high sodium intake the scientific literature has established a link between dietary fat and increased risk of hypertension [9] . In this sense, we found gene-diet interactions between rs1799983 NOS3 genetic variant and SFA and MUFA intakes and the effect on DBP. This outcome diverges from the results of Kingah et al. [32] that did not find any interaction between the NOS3 genetic variant and dietary fat (total fat, SFA, MUFA and polyunsaturated fatty acids (PUFA)). Nevertheless, our observations are consistent with the results of Pereira et al. [33] that suggested a possible gene-diet interaction between rs1799983 and a diet rich in SFA and cholesterol to influence BP levels. However, the mechanisms by which dietary fat modulates the effect of NOS3 genetic variant on BP levels are unknown and can at best only be speculated. In line of our results, it has been reported in a molecular model that a diet rich in olive oil (high MUFA diet) increased the expression of the NOS3 enzyme. In contrast, a diet rich in SFA decreased the expression of NOS3 [34] . Thus, we hypothesized that carriers of the T allele presented lower effect to dietary fat due to a reduced function of NOS3. To establish the mechanism by which dietary fat intake influences BP depending on the NOS3 genotype, more studies are needed.
Interestingly, this study has found a novel interaction between BMI and rs1799983 on the modulation of DBP levels. This observation is consistent with the results of Abdel-Aziz et al. [11] , who described that the association of obesity with TT genotype of rs1799983 polymorphism increased the risk to develop premature coronary artery disease in Egyptians. Moreover, previous studies have identified the influence of obesity on the relationship between different polymorphisms and BP levels or hypertension among adults and children [35] [36] [37] . Initial epidemiological studies suggesting a relationship between obesity and BP levels have been supported with the understanding of potential mechanisms involved in both conditions, such as vascular and systemic insulin resistance, dysfunction of the sympathetic nervous system and the renin-angiotensinaldosterone system, among other pathogenetic factors [10, 38] . On the other hand, NOS3 protein content was shown to be significantly lower in overweight and obese people and inversely associated with body fat mass [39, 40] . Moreover, oxidative stress, a well-known process implicated in obesity, has been related to NOS3 response. In this regard, a previous study in an animal model suggested that a reduced NO production and an increased production of reactive oxygen species (ROS) may contribute to hypertension in obese rats [41] . Therefore, such scientific evidence suggests that our result may be a genuine interaction rather than a random chance finding.
The present study bears some strengths and limitations that need to be mentioned. First, this study included only subjects of Caucasian ancestry, so our findings may not be generalizable to other ethnic populations. Second, the study site could be considered as a random effect. However, when the statistical analysis was carried out adjusted for the covariate region the analysis gave similar results (data not shown). Third, due to the relatively small sample size and the use of a nominal significance threshold p value <0.05, the findings may need to be replicated in other population. Nevertheless, it was large enough to provide us adequate statistical power and the associations and interactions have reached statistical significance in this context of limited sample size. Fourth, we did not exclude subjects with diagnosed hypertension. However, the adjustments of SBP and DBP according to diagnostic hypertension avoided the possibility that a biased selection might result from selecting only individuals without hypertension. This correction has been widely adopted for different authors [14] [15] [16] [17] . Fifth, non-genetic factors could influence BP levels. In this sense, multivariate adjustments support that the effects are independent of some common traditional hypertension risk factors, including age, BMI, physical activity, smoking and alcohol consumption. However, sodium intake was not taken into account, although it would be of interest to be included in the analysis, but unfortunately data were not available. Finally, as a cross-sectional study, to get definitive clinical conclusions about dietary intake may be elusive.
The present research represents a pilot effort to explore the role of gene-environment interactions in BP levels. The investigation of genetic factors and their interactions with the environment may improve the selection of more individualized effective treatment of hypertension.
